skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Mismatch between iodine-123 IMP and technetium-99m HM-PAO brain perfusion imaging in a patient with meningioma

Journal Article · · Clin. Nucl. Med.; (United States)

The discrepancy between three methods for cerebral perfusion imagings in the case of a man with meningioma is presented. Imaging with N-isopropyl-P-(I-123) iodoamphetamine (IMP) showed no activity in the tumor. Imaging with Tc-99m hexamethylpropyleneamine oxime (HM-PAO) and the local cerebral blood flow (LCBF) image with Xe-133 inhalation showed high tumor activity. IMP is a more accurate method for imaging the brain tissue blood flow.

Research Organization:
Miyazaki Medical College, Kihara, Japan
OSTI ID:
5782138
Journal Information:
Clin. Nucl. Med.; (United States), Vol. 12:9
Country of Publication:
United States
Language:
English

Similar Records

Dynamic SPECT with technetium-99m HM-PAO in meningiomas--a comparison with iodine-123 IMP
Journal Article · Thu Jun 01 00:00:00 EDT 1989 · J. Nucl. Med.; (United States) · OSTI ID:5782138

Comparative study of regional cerebral blood flow images by SPECT using xenon-133, iodine-123 IMP, and technetium-99m HM-PAO
Journal Article · Wed Feb 01 00:00:00 EST 1989 · J. Nucl. Med.; (United States) · OSTI ID:5782138

Technetium-99m-d, 1-HM-PAO: a new radiopharmaceutical for imaging regional brain perfusion using SPECT--a comparison with iodine-123 HIPDM
Journal Article · Mon Dec 01 00:00:00 EST 1986 · J. Nucl. Med.; (United States) · OSTI ID:5782138